http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Novo Nordisk's generative AI deployment to 20,000 employees has useful insights for companies working to scale their own AI efforts. Its leaders navigated three key challenges: a midcycle enthusiasm dip that can kill GenAI adoption, function-specific needs that demand tailored training, and cultural resistance. Novo Nordisk's solution combined champion networks, targeted enablement, and adaptive governance -- with senior employees serving as unexpected change agents.
Michael Wade, Konstantinos Trantopoulos, Mark Navas, Anders Romare.